Primary cutaneous CD30-positive anaplastic large cell lymphoma (Q39144): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
 
(6 intermediate revisions by the same user not shown)
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1972636482 / rank
 
Normal rank
Property / CURIE
 
CID11:2B03.0
Property / CURIE: CID11:2B03.0 / rank
 
Normal rank
Property / Canary Token
 
dki-india-2B03.0
Property / Canary Token: dki-india-2B03.0 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: C86.6 / rank
 
Normal rank

Latest revision as of 04:27, 13 August 2026

An anaplastic large cell lymphoma that is limited to the skin at the time of diagnosis. Most patients present with solitary or localised skin lesions in a form of nodules or papules, which may be tumours. The t(2;5) translocation that is present in many cases of systemic anaplastic large cell lymphoma is not found in this disease.
Language Label Description Also known as
default for all languages
2B03.0
    English
    Primary cutaneous CD30-positive anaplastic large cell lymphoma
    An anaplastic large cell lymphoma that is limited to the skin at the time of diagnosis. Most patients present with solitary or localised skin lesions in a form of nodules or papules, which may be tumours. The t(2;5) translocation that is present in many cases of systemic anaplastic large cell lymphoma is not found in this disease.

      Statements

      CID11:2B03.0
      0 references
      dki-india-2B03.0
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references